Cardioversion Safety − Are We Doing Enough?

There is a considerable periprocedural risk of thromboembolic events in atrial fibrillation patients undergoing cardioversion, and treatment with anticoagulants is therefore a hallmark of cardioversion safety. Based on retrospective subgroup analyses and prospective studies, non-vitamin K anticoagul...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiology
Main Authors: Khatami, Mohsen, Pope, Marita Knudsen, Le Page, Sophie, Radic, Petra, Schirripa, Valentina, Grundvold, Irene, Atar, Dan
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2020
Teme:
AF and Stroke: Editorial
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677998/
https://ncbi.nlm.nih.gov/pubmed/32898849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509343
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki